Fresenius Recalls One Lot of Contaminated Vials

Fresenius Kabi has recalled one lot of Magnesium Sulfate Injection, USP due to contamination of visible glass particles in the vials. Fresenius voluntarily recalled this lot as a safety measure in order to safely inspect the product further.

To date no consumers have reported any adverse reactions to previously released lots of the solution. All patients who received the effected solutions, which were distributed between May 2012 and June 2012, have been notified. The labels read a product code 6450, 500mg/mL strength, and are in 50mL glass vials, with 25 vials per tray.

The medication magnesium sulfate is normally used intravenously to replace depleted electrolyte levels and as an anticonvulsant.

Glass contamination in medical solutions have been known to cause aftereffects of thromboembolism, phlebitis, arteriole and capillary blockage, increased platelet activation, emboli and granulomas.

If you or anyone you know have been affected by this recall, contact our attorneys today.